🎉 Health Canada Provides a No Objection Letter for ATMA’s N500 Phase II Clinical Trial Application
CALGARY, ALBERTA, CANADA, January 25, 2023 /EINPresswire.com/ — In response to the new Alberta Regulations on psychedelic assisted therapy, ATMA Journey Centers Inc. (“ATMA”), Canada’s leading psychedelic-assisted therapy training provider, has announced …
CALGARY, ALBERTA, CANADA, January 18, 2023 /EINPresswire.com/ — ATMA Journey Centers Inc. (“ATMA”), Canada’s leading psychedelic-assisted therapy training provider, is pleased to announce it will be offering the first psychedelic training …
ATMA Offers the First Psychedelic Training Program for Physicians and Prescribers Read More »
KINGSTON, ONTARIO, CANADA, January 5, 2023 /EINPresswire.com/ — ATMA Journey Centers Inc. (“ATMA”), a Canada’s leading psychedelic-assisted therapy training providers, is pleased to announce their affiliate partnership with Neuma Centre, Kingston’s first …
Copyright © 2023 ATMA
